In collaboration with:
Organised by:
Dr. Radhakrishna Sothiratnam is currently in Columbia Asia Group Malaysia as Diabetic Project Lead. He acquired his MBBS from University of Mangalore then became a Member of Royal Colleges of Physicians of United Kingdom from University of Edinburgh in 1987 and 1996 respectively. He was previously the Consultant Physician in General Medicine appointed by the Ministry of Health Malaysia in 1998.
He was a medical registrar; then as a clinical specialist in Department of Medicine, General Hospital Seremban from 1994 until 1999. He later became a lecturer in Department of Internal Medicine, International Medical University (IMU) Kuala Lumpur, IMU Clinical School, Seremban from 1999 until 2000. He is currently the resident internal medicine physician since 2000.
He was an instructor, examiner, and lecturer in 3 institutions during the 9 years since 1994 and as an invited speaker, workshop facilitator, and debater for CPD Programs and Events by different parties since 2001. In 2008, he became a Certified speaker by American Diabetes Association, as well as an examiner for MRCP-PACES Mock Exam in Seremban General Hospital.
Since 2004, he has been the principal investigator for 16 research topics. He was also the principal coordinating investigator for Malaysia in iDISCOVER in 2015. Since 2007, he had done 2 poster presentations and had 2 publications focusing on the efficacy and safety of antidiabetic medications.
He held various key positions in Malaysian Medical Association since 1998 including council member, executive committee member, secretary, vice-chairman and chairman. He then received his National MMA Branch Long Service Gold Medal Award in 2007 as recognition of his service. He was a guest in various bodies including radio broadcast and campaigns.
Recently, he has delivered 30 topics on Type 2 Diabetes throughout 9 countries since August 2013 and is currently a member of International Speakers’ Bureau and advisory board in Asia-Pacific Region. He also provides research contracts and technical support, paid consultancy, as well as lecture honorarium in various pharmaceutical companies.
